ONCODEduce MDS Mutation 37-gene NGS Panel
Product Description:
NGS Panel targeting 37 gene mutations that allows a broader exploration of the gene frequently implicated in the diagnosis, treatment and prognostication of MDS.
Highlighted Genes -- ASXL1, DNMT3A, EZH2, KRAS, NPM1, NRAS, RUNX1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 etc.
Technique:
Next Generation Sequencing (NGS)
Test Methodology:
DNA extracted from blood/ marrow/ aspirate smears is subjected to amplification-based library preparation and massively parallel sequencing. Sequencing analysis is performed using commercial bioinformatics pipelines and annotation is done using proprietary and public databases.
Specimen Requirements:
3ml of Blood or Marrow Aspirate in EDTA tube or
2 aspirate smears with adequate cellularity
Turn Around Time:
15 working days
Shipment Requirement:
Keep specimen at room temperature. DO NOT ship on ice or dry ice or expose to direct sunlight.